GARCEAU ROGER
Insider CIK 1451767 · TARA Director · ENTX Director · NPSP SVP &CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 31,000 | — | $0 | 31,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2024-01-01 | 2024-01-03 | 108,333 | — | $0 | 108,333 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2023-01-02 | 2023-01-04 | 89,041 | — | $0 | 89,041 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2022-01-01 | 2022-01-11 | 35,852 | — | $0 | 35,852 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2022-01-01 | 2022-01-11 | 107,557 | — | $0 | 107,557 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award | 2020-01-10 | 2020-01-13 | 33,000 | — | $0 | 33,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 12,399 | — | $0 | 12,399 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 10,491 | — | $0 | 10,491 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 12,399 | — | $0 | 12,399 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 25,998 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 25,179 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,531 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 84,941 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 30,615 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,905 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 7,665 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 9,900 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 43,349 | $46.00 | $1.99M | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-13 | 2015-02-20 | 10,531 | — | $0 | 10,531 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-13 | 2015-02-20 | 5,460 | $45.88 | $250.5K | 43,349 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-13 | 2015-02-20 | 10,531 | — | $0 | 48,809 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 3,832 | — | $0 | 7,665 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 10,905 | — | $0 | 10,905 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 3,832 | — | $0 | 39,842 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-12 | 2015-02-20 | 1,564 | $45.85 | $71.7K | 38,278 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | G Gift | 2015-02-10 | 2015-02-12 | 11,000 | — | $0 | 41,448 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2015-02-07 | 2015-02-20 | 15,168 | — | $0 | 41,448 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-07 | 2015-02-20 | 5,438 | $45.85 | $249.3K | 36,010 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-05 | 2015-02-09 | 15,384 | $45.88 | $705.8K | 52,448 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 10,530 | — | $0 | 21,062 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 10,530 | — | $0 | 71,754 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-13 | 2014-02-14 | 3,922 | $38.30 | $150.2K | 67,832 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 11,497 | — | $0 | 11,497 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 31,474 | — | $0 | 31,474 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-07 | 2014-02-11 | 5,371 | $35.13 | $188.7K | 61,224 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2014-02-07 | 2014-02-11 | 15,167 | — | $0 | 66,595 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-01-07 | 2014-01-09 | 15,000 | — | $0 | 125,758 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 1,622 | — | $0 | 8,378 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 26,383 | — | $0 | 28,617 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 60,000 | — | $0 | 20,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 12,620 | — | $0 | 27,380 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 9,375 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 9,375 | $5.98 | $56.1K | 147,763 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 74,242 | $3.34 | $248.0K | 138,388 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 26,383 | $8.25 | $217.7K | 174,146 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-08-30 | 2013-09-04 | 110,000 | $25.18 | $2.77M | 64,146 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-02-19 | 2013-02-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-02-19 | 2013-02-21 | 27,500 | — | $0 | 73,849 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-19 | 2013-02-21 | 9,703 | $8.01 | $77.7K | 64,146 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 84,941 | — | $0 | 84,941 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 31,592 | — | $0 | 31,592 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-07 | 2013-02-11 | 5,586 | $8.61 | $48.1K | 46,349 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 15,165 | — | $0 | 51,935 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-12-21 | 2012-12-21 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2012-10-03 | 2012-10-05 | 140,625 | — | $0 | 9,375 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2012-10-03 | 2012-10-05 | 140,625 | $9.51 | $1.34M | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2012-10-03 | 2012-10-05 | 140,625 | $5.98 | $840.9K | 140,625 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-02-07 | 2012-02-09 | 39,600 | — | $0 | 39,600 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 45,500 | — | $0 | 45,500 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-30 | 2012-02-01 | 40,000 | — | $0 | 40,000 | SEC↗ |